International

COVID-19 vaccine protects 94% of adults over 65

The coronavirus vaccine developed by Pfizer and BioNTech appears to protect 94% of adults over 65 years old.

More data released from their ongoing phase three trial suggests it works equally well in people of all races and ethnicities.

The companies say they will now apply for authorisation for emergency use of the jab in the US.

The findings are based on two doses given to more than 41,000 people around the world.

Last week, Pfizer and BioNTech published preliminary data showing the vaccine offered 90% protection against Covid-19 and there were no safety concerns.

Click to comment

Leave a Reply

Your email address will not be published.

Most Popular

To Top
$(".comment-click-2777").on("click", function(){ $(".com-click-id-2777").show(); $(".disqus-thread-2777").show(); $(".com-but-2777").hide(); }); // Infinite Scroll $('.infinite-content').infinitescroll({ navSelector: ".nav-links", nextSelector: ".nav-links a:first", itemSelector: ".infinite-post", loading: { msgText: "Loading more posts...", finishedMsg: "Sorry, no more posts" }, errorCallback: function(){ $(".inf-more-but").css("display", "none") } }); $(window).unbind('.infscr'); $(".inf-more-but").click(function(){ $('.infinite-content').infinitescroll('retrieve'); return false; }); $(window).load(function(){ if ($('.nav-links a').length) { $('.inf-more-but').css('display','inline-block'); } else { $('.inf-more-but').css('display','none'); } }); $(window).load(function() { // The slider being synced must be initialized first $('.post-gallery-bot').flexslider({ animation: "slide", controlNav: false, animationLoop: true, slideshow: false, itemWidth: 80, itemMargin: 10, asNavFor: '.post-gallery-top' }); $('.post-gallery-top').flexslider({ animation: "fade", controlNav: false, animationLoop: true, slideshow: false, prevText: "<", nextText: ">", sync: ".post-gallery-bot" }); }); });